Vernon Bernardino
Stock Analyst at HC Wainwright & Co.
(2.61)
# 2,072
Out of 4,784 analysts
204
Total ratings
23.19%
Success rate
0.57%
Average return
Main Sectors:
Stocks Rated by Vernon Bernardino
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SAVA Cassava Sciences | Reiterates: Neutral | $2 | $1.65 | +21.21% | 24 | Mar 25, 2025 | |
| MBRX Moleculin Biotech | Reiterates: Buy | $8 | $1.04 | +669.23% | 4 | Mar 25, 2025 | |
| NRXP NRx Pharmaceuticals | Reiterates: Buy | $19 | $2.03 | +835.96% | 7 | Mar 20, 2025 | |
| CADL Candel Therapeutics | Reiterates: Buy | $19 | $5.95 | +219.60% | 7 | Mar 14, 2025 | |
| EDSA Edesa Biotech | Reiterates: Buy | $21 | $2.50 | +740.00% | 11 | Mar 13, 2025 | |
| HUMA Humacyte | Reiterates: Buy | $15 | $1.96 | +665.31% | 6 | Mar 12, 2025 | |
| AEMD Aethlon Medical | Reiterates: Buy | $7 | $0.37 | +1,808.92% | 9 | Mar 10, 2025 | |
| ENVB Enveric Biosciences | Reiterates: Buy | $10 | $1.47 | +580.27% | 2 | Mar 6, 2025 | |
| SENS Senseonics Holdings | Reiterates: Buy | $2 | $0.68 | +196.08% | 9 | Mar 5, 2025 | |
| ARTL Artelo Biosciences | Reiterates: Buy | $5 | $0.94 | +431.91% | 11 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.96 | +837.50% | 8 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.29 | +210.08% | 6 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $7.00 | +171.43% | 22 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $350 | $1.56 | +22,335.90% | 2 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $3.35 | +377.61% | 9 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.11 | +620.72% | 14 | Nov 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $1.37 | +337.96% | 7 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $100 | $1.55 | +6,351.61% | 9 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.48 | +1,117.20% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $1.21 | +1,552.89% | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $175,000 → $15,750 | $4.05 | +388,798.49% | 3 | Mar 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.72 | +3,367.41% | 8 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $17.35 | +1,283.29% | 4 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.88 | +8,940.57% | 1 | Oct 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $100 | $1.45 | +6,796.55% | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $8,000 | $6.49 | +123,166.56% | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $7 | $1.65 | +324.24% | 2 | Aug 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 → $30 | $2.70 | +1,011.11% | 1 | Mar 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $40 | $2.78 | +1,338.85% | 1 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $0.24 | +7,440.85% | 1 | Jan 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.52 | +228.95% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $1,440 | $2.79 | +51,512.90% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $24 | $43.19 | -44.43% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,420 | $1.59 | +214,994.34% | 1 | Oct 6, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19,000 | $2.79 | +680,903.58% | 1 | Oct 6, 2017 |
Cassava Sciences
Mar 25, 2025
Reiterates: Neutral
Price Target: $2
Current: $1.65
Upside: +21.21%
Moleculin Biotech
Mar 25, 2025
Reiterates: Buy
Price Target: $8
Current: $1.04
Upside: +669.23%
NRx Pharmaceuticals
Mar 20, 2025
Reiterates: Buy
Price Target: $19
Current: $2.03
Upside: +835.96%
Candel Therapeutics
Mar 14, 2025
Reiterates: Buy
Price Target: $19
Current: $5.95
Upside: +219.60%
Edesa Biotech
Mar 13, 2025
Reiterates: Buy
Price Target: $21
Current: $2.50
Upside: +740.00%
Humacyte
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.96
Upside: +665.31%
Aethlon Medical
Mar 10, 2025
Reiterates: Buy
Price Target: $7
Current: $0.37
Upside: +1,808.92%
Enveric Biosciences
Mar 6, 2025
Reiterates: Buy
Price Target: $10
Current: $1.47
Upside: +580.27%
Senseonics Holdings
Mar 5, 2025
Reiterates: Buy
Price Target: $2
Current: $0.68
Upside: +196.08%
Artelo Biosciences
Mar 4, 2025
Reiterates: Buy
Price Target: $5
Current: $0.94
Upside: +431.91%
Feb 24, 2025
Reiterates: Buy
Price Target: $9
Current: $0.96
Upside: +837.50%
Feb 19, 2025
Reiterates: Buy
Price Target: $4
Current: $1.29
Upside: +210.08%
Dec 10, 2024
Reiterates: Buy
Price Target: $19
Current: $7.00
Upside: +171.43%
Dec 4, 2024
Reiterates: Neutral
Price Target: $350
Current: $1.56
Upside: +22,335.90%
Nov 20, 2024
Reiterates: Buy
Price Target: $16
Current: $3.35
Upside: +377.61%
Nov 20, 2024
Reiterates: Buy
Price Target: $8
Current: $1.11
Upside: +620.72%
Nov 14, 2024
Reiterates: Buy
Price Target: $6
Current: $1.37
Upside: +337.96%
Nov 12, 2024
Reiterates: Buy
Price Target: $100
Current: $1.55
Upside: +6,351.61%
Nov 12, 2024
Reiterates: Buy
Price Target: $18
Current: $1.48
Upside: +1,117.20%
May 31, 2023
Reiterates: Buy
Price Target: $20
Current: $1.21
Upside: +1,552.89%
Mar 31, 2023
Reiterates: Buy
Price Target: $175,000 → $15,750
Current: $4.05
Upside: +388,798.49%
Mar 8, 2023
Reiterates: Buy
Price Target: $25
Current: $0.72
Upside: +3,367.41%
Mar 7, 2023
Reiterates: Buy
Price Target: $240
Current: $17.35
Upside: +1,283.29%
Oct 7, 2022
Initiates: Buy
Price Target: $80
Current: $0.88
Upside: +8,940.57%
Jun 30, 2021
Initiates: Buy
Price Target: $100
Current: $1.45
Upside: +6,796.55%
Dec 29, 2020
Initiates: Buy
Price Target: $8,000
Current: $6.49
Upside: +123,166.56%
Aug 26, 2020
Maintains: Buy
Price Target: $4 → $7
Current: $1.65
Upside: +324.24%
Mar 11, 2020
Reiterates: Buy
Price Target: $75 → $30
Current: $2.70
Upside: +1,011.11%
Feb 25, 2020
Initiates: Buy
Price Target: $40
Current: $2.78
Upside: +1,338.85%
Jan 13, 2020
Initiates: Buy
Price Target: $18
Current: $0.24
Upside: +7,440.85%
Oct 6, 2017
Initiates: Buy
Price Target: $5
Current: $1.52
Upside: +228.95%
Oct 6, 2017
Initiates: Buy
Price Target: $1,440
Current: $2.79
Upside: +51,512.90%
Oct 6, 2017
Initiates: Buy
Price Target: $24
Current: $43.19
Upside: -44.43%
Oct 6, 2017
Initiates: Buy
Price Target: $3,420
Current: $1.59
Upside: +214,994.34%
Oct 6, 2017
Initiates: Buy
Price Target: $19,000
Current: $2.79
Upside: +680,903.58%